Xerophthalmia Clinical Trial
Official title:
A Randomized, Double-blind, Parallel, Placebo-Controlled, Single and Multiple Ascending Dose Phase 1 Clinical Study to Assess the Safety, and Local Tolerance, Pharmacokinetics After Application of NCP112 Eye Drop in Healthy Subjects
The objective is to evaluate the safety, local tolerability, and pharmacokinetics of NCP112 eye drops through single and multiple dose-escalation ocular administrations in healthy adults.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04636372 -
Effect of Meibomian Gland Related Therapy on the Morphology of Meibomian Gland
|
N/A | |
Completed |
NCT03753893 -
Ocular Manifestations in Rheumatic Diseases
|
||
Completed |
NCT01089985 -
Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye
|
Phase 1 | |
Completed |
NCT00796926 -
Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes
|
Phase 3 | |
Withdrawn |
NCT02655432 -
Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
|
Phase 0 | |
Recruiting |
NCT04877483 -
To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome
|
N/A | |
Completed |
NCT05656196 -
VGH-DESJS-1 in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome and Sjögren's Syndrome
|
N/A |